Introduction
Duplications on the long arm of the X-chromosome include intrachromosomal duplications and partial disomies or trisomies resulting from unbalanced translocations with an autosome or Y chromosome. Males with Xq duplications are relatively rare but the increasing use of genome wide molecular cytogenetic studies has identified a growing number of smaller Xq imbalances with a major locus on Xq28 including the MECP2 gene (Bauters et al. 2008; lugtenberg et al. 2006; ramocki et al. 2010; van esch et al. 2005; veltman et al. 2004) . sanlaville et al. (2009) compared three groups of males with Xq duplications: distal (Xq26.3-qter), proximal (Xq21-q24) and MECP2 duplications only and concluded that they all share common, non-specific, clinical features including intellectual disability (ID), hypotonia, hypogonadism and feeding difficulties. this overlap in phenotype despite discordant Xq duplications was also postulated in a previous study (Cheng et al. 2005) suggesting that there is a common, rather nonspecific phenotype, associated with Xq duplications in general. Usually, females with duplications on the X-chromosome are phenotypically normal, as in most cases the duplicated region is subjected to inactivation. However, in females with Xq duplications ID and various other features have been reported (armstrong et al. 2003; aughton et al. 1993; Garcia-Heras et al. 1997; ricks et al. 2010; sanlaville et al. 2005; stankiewicz et al. 2005; tachdjian et al. 2004) . the prevalence of duplications comprising more proximal regions of Xq is yet unknown and duplications of Xq25 and Xq26 have been reported in only a few cases (armstrong et al. 2003; Bauters et al. 2005; Garcia-Heras et al. 1997; Madrigal et al. 2010; ricks et al. 2010; schroer et al. 2012; stankiewicz et al. 2005; tachdjian et al. 2004 ). these involve larger duplications, described mainly by conventional cytogenetic studies or microsatellite marker analyses. In this study we report the clinical and molecular characterization of eight unrelated families with interstitial microduplications involving Xq25q26.
Patients and methods
Patients eight families were identified through systematic screening for submicroscopic chromosomal imbalances in patients with cognitive disabilities and/or dysmorphic features. the clinical evaluation consisted of a comprehensive medical history, family history, growth measurements and 1 3 dysmorphology examination. all participants have given written informed consent according to the regulations at their local institutional review boards.
Molecular karyotyping
Family I was examined using agilent 244k oligonucleotide-based microarray analysis (agilent technologies). In family II, snP array analysis was performed using the affymetrix 250k snP array platform according to the standard affymetrix GeneChip protocol (affymetrix Inc, santa Clara, Ca, Usa). In family III, array CGH in the index patient was performed using the agilent 44K oligonucleotide-based microarray and further confirmed by a 105k array (Oxford design). this 105k array was also applied to test segregation of the Xq duplications in family members. Family Iv was examined using agilent 400K whole-genome oligonucleotide-based microarray analysis (agilent technologies, santa Clara, Ca, Usa). In family v, an agilent 44K oligonucleotide-based microarray was used to detect the duplication. Family vI was examined using agilent 60K whole-genome oligonucleotide-based microarray analysis (agilent technologies, santa Clara, Ca, Usa). the duplications in family vII and vIII were identified using an X-chromosome-specific array CGH ) and agilent 244K oligonucleotidebased microarray (agilent technologies, santa Clara, Ca, Usa), respectively. For the interpretation of the array results, the UCsC Human Genome Browser: (Hg19, February 2009) (http://genome.ucsc.edu/) was used. the duplications were confirmed by either fluorescence in situ hybridization (FIsH) with bacterial artificial chromosome (BaC) Dna probes, quantitative rt-PCr (qPCr) and/or by multiplex ligation-based probe amplification (MlPa) according to standard protocols.
X-inactivation studies
Inactivation status of the X-chromosomes was determined on Dna from lymphocytes using the androgen receptor gene (AR) methylation assay (allen et al. 1992) in families I-vI and a slightly modified FMR1 (fragile X-mental retardation) methylation assay (lee et al. 1994) in families I-Iv. the X-inactivation was defined as being skewed if more than 80 % of the investigated cells inactivated the same chromosome.
Quantitative rt-PCr total rna was isolated using the PaXgene Blood rna system (PreanalytiX GmbH, Hombrechtikon, CH). the expression levels were measured by qrt-PCr in a lightCycler 480 using lightCycler 480 sYBr Green I Master chemistry (roche, applied science). the data were evaluated using the basic relative quantitation algorithm provided with the lightCycler 480 software. For normalization we used 12 housekeeping genes to dilute out the expression variability of single housekeeping genes.
next-generation paired-end sequencing Mate pair libraries were prepared using the Mate Pair library v2 kit (Illumina, san Diego, Ca, Usa). Briefly, 10 μg Dna was sheared using a nebulizer. two-to three kb pair fragments were isolated, end-repaired using a mix of natural and biotinylated dntPs, blunt-end ligated using circularization ligase and fragmented to 200-400 bp. Biotinylated fragments were isolated and end-repaired and a-overhangs were added to the 3′-ends. Paired-end adapters were ligated to the fragments and the library was amplified by 18 cycles of PCr. Mate pair libraries were subjected to 2 × 36 bases paired-end sequencing on a Genome analyzer IIx (Illumina, san Diego, Ca, Usa), following the manufacturer's protocol. reads were aligned to a reference genome using Bowtie allowing up to two mismatches in the seed region. reads not aligning uniquely were discarded from further analysis. Genomic sequences flanking breakpoints were extracted from the UCsC Genome Browser. Composite sequences mimicking the duplication were constructed and masked for repetitive sequences using repeatmasker (http://www.repeatmasker.org/cgibin/WeBrepeatMasker) to avoid designing primers within repetitive sequences. Primers for PCr were designed using Oligo6 software (Molecular Biology Insights). Primer sequences can be obtained upon request. PCr was performed on genomic Dna from duplication carriers and a normal control as templates. the PCr fragments were separated on agarose gel, and the specific bands in the duplication carrier were excised, purified and sequenced on an aBI 3130Xl genetic analyzer (life technologies) using BigDye terminator chemistry, essentially as described by the manufacturer. the sequences were aligned to composite sequences using Dialign (http://bibiserv.techfak.unibielefeld.de/dialign/submission.html) to identify breakpoints. If sequences did not span a breakpoint, new primer sets were designed until spanning PCr products were obtained. some PCr products were cloned using tOPO ta cloning (life technologies). Breakpoints were verified by second independent primer-sets.
Gpc3 transgenic mice
We made use of an already generated transgenic mouse model to study effects of overexpression of Gpc3 (Capurro et al. 2005) . We measured the weight of these Gpc3 transgenic mice where Gpc3 expression is driven by the β-actin promoter and compared with normal littermates.
littermates were weighed at birth (nB), and 1, 2, 3, 4 and 5 weeks after birth (W1, W2, W3, W4 and W5, respectively). For statistical analysis we used the student t test.
Results

extent and size of the Xq25q26 duplications
Using various genome-wide array platforms, we identified overlapping interstitial Xq25q26 duplications ranging from 0.2 to 4.76 Mb in size in eight unrelated families (Fig. 1) . none of the index patients showed other pathogenic copy number variations or microscopically visible chromosome rearrangements with conventional cytogenetic analysis. In families I-vI, the duplication was associated with a recognisable phenotype in five males and seven females, whereas the duplication in families vII and vIII was evaluated as a non-pathogenic variation as it was also present in unaffected males. Families I-Iv and vI-vIII were Caucasian and family v Pakistani.
Family I comprised three affected individuals, i.e. a mother and her two sons (Fig. 2a-f the left vertical box highlights the smallest region of overlap (srO) for the intellectual disabilities observed in families I-III and vI. the region contains two genes, AIFM1 and RAB33A. the middle vertical box highlights the srO for bilateral ptosis, microcephaly and digital defects present in families II-v. this region contains FAM45B and ENOX2. the horizontal bracket shows the srO for syndromic facial appearance, cleft palate, small hands and feet and severe genital abnormalities. the right vertical box highlights the 0.9 Mb polymorphic region, which can be excluded to be disease causing as the duplication of this region has been observed in the unaffected males in families vII and vIII duplication at chromosome position X: 127, 779, 069-129, 388, 972 (the first and the last aberrant oligonucleotides are a_16_P03766957 and a_16_P21589318, respectively). the duplication was confirmed by FIsH and appeared to be in tandem (results not shown). array CGH revealed the same duplication in the affected mother and the affected brother.
Family II comprised two affected individuals, i.e. a mother and son ( Fig. 3a-c ). 250K snP array revealed a 4.7-Mb duplication at chromosome position X: 128, 692, 319-133, 372, 334 (first and last aberrant snPs are snP_a-4224853 and snP_a-1837089, respectively) in both. It was verified by MlPa. the phenotypically normal maternal grandmother did not have the duplication and Dna was not available from the phenotypically normal maternal grandfather. However, snP evaluation suggested that the duplication was de novo occurring on the grandmaternal allele.
Family III comprised two affected individuals, i.e. a male index patient and his mother (Fig. 3d, f) . 44K oligonucleotide-based microarray revealed a 4.76-Mb interstitial duplication (the first and the last aberrant oligonucleotides s are a_14_P135020 and a_14_P122873, respectively; chrX: 129, 213, 749-133, 979, 440) in the index patient and in his mother. the result was confirmed with MlPa and FIsH (results not shown). the phenotypically normal maternal grandparents showed normal array profiles.
Family Iv comprised two affected individuals, i.e. index patient and his mother ( Fig. 3g) . High-resolution comparative genome hybridization analysis of the index patient showed an interstitial duplication of Xq25q26, which was maternally inherited. a 400-K whole-genome oligonucleotide microarray was used to fine map the duplication to chrX: 129, 321, 169-133, 860, 490 (4.54 Mb; the first and the last aberrant oligonucleotides are a_16_P03768999 and a_16_P21599361, respectively).
Family v comprised one affected girl (Fig. 2h ). 44K oligonucleotide-based microarray analysis revealed a 207-kb interstitial duplication at chromosome position chrX: 129, 630, 006-129, 837, 225 (the first and the last aberrant oligos are a_14_P115358 and a_14_P130575, respectively). the duplication was inherited from the phenotypically normal mother.
Family vI comprised two affected females. Oligonucleotide-based microarray analysis 60K oligo-array) revealed a 985-kb interstitial duplication of Xq25q26.1 at chromosome position chrX: 128, 321, 815-129, 307, 056 (the first and the last aberrant oligos are a_14_P111254 and a_14_ P133293, respectively).
In Family vII and vIII array CGH revealed a 0.9 Mb (chrX: 130, 571, 352, 535) and 0.7 Mb (chrX: 130, 841, 525, 341) interstitial duplication of Xq26, respectively. segregation analysis was performed, and both duplications were found in healthy male Clinical evaluations all five male duplication carriers from family I-Iv showed a common phenotype including intrauterine growth retardation and feeding difficulties in childhood (table 1) . they all had various facial dysmorphic signs, comprising a broad nasal tip with thickened alae nasi, bilateral ptosis and large protruding ears (family I-Iv) and cleft palate (family II and Iv) (Figs. 2, 3) . Furthermore, the probands of family II, III and Iv had digital anomalies, such as arthrogryposis, camptodactyly, syndactyly, clinodactyly (supplementary Fig. I ) and genital abnormalities, such as hypospadia and a small penis and testes. the male probands in all families, except for family Iv, had ID, small head circumference/microcephaly and short stature. all the female duplication carriers showed similar, but milder features including normal cognitive development, except for the mother in family I and the females in family vI, who had borderline ID (table 2) . all the females had short stature and small hands and feet. In families II-v, the carrier females had digital defects; in families II, Iv and v bilateral ptosis; and in family vI facioscapulohumeral dystrophy (Figs. 2, 3 and supplementary Fig. I ).
X-inactivation studies
Inactivation status of the X-chromosomes in carrier females was determined on Dna from lymphocytes using the AR methylation assay in families I-vI and a slightly modified FMR1 methylation assay in families I-Iv. In the female duplication carriers from families II-Iv the X-chromosome harbouring the duplication was preferentially inactivated both for the AR and FMR1 loci (100:0) (supplementary table 1). In the female duplication carrier in family I the normal X-chromosome was preferentially inactivated (4:96). the mother and the affected daughter in family v showed random X-inactivation in lymphocytes. the females in family vI showed complete skewing of X-inactivation.
mrna expression studies the affected males from family I, II and III share a 107-kb region of overlap, which includes two genes, AIFM1 and RAB33A. to investigate the transcriptional level of RAB33A and AIFM1 we obtained blood from the three affected and two unaffected individuals (healthy brother and father of the index patient) of family I. the expression levels were measured by qrt-PCr. the expression values were normalized against that of the unaffected father, which was set to 1 for each of the duplicated genes. Both RAB33A and AIFM showed higher expression in the affected brothers compared with the mother and the unaffected males from the family. In addition, we performed qrt-PCr on different human brain tissues showing that both RAB33A and AIFMI are highly expressed in the brain (data not shown), suggesting that dysregulation of RAB33A and AIFMI may be related to the ID observed in family I and in the other patients. the affected males and females from families II, III and Iv and the female from family v exhibit bilateral ptosis, small head circumference/microcephaly and digital defects, suggesting that the 200-kb common duplicated region in these families is critical for these features. the 200-kb region includes only two genes, ENOX2 and FAM45B. We investigated the transcriptional level of ENOX2 and FAM45B in blood lymphocytes from the affected female of family v and from her unaffected parents. However, the mrna expression level did not differ significantly in the affected female as compared with her unaffected parents and four healthy controls (supplementary Fig. II ).
Fine mapping of chromosomal breakpoints the duplications examined in this study vary in size and show different proximal and distal breakpoints in all cases. Fine mapping of the duplication breakpoints in family vI was performed using the next-generation paired-end sequencing followed by PCr cloning which provided base pair resolution; proximal breakpoint: chrX: 128, 280, 363 and distal breakpoint: chrX: 129, 319, 480. a five bp (tttGt) deletion was observed 35 bp downstream of the distal breakpoint. Both breakpoints were placed outside of genes; however, the distal breakpoint was located only approximately 600 bp from the 3′ Utr of RAB33A. the results showed that the breakpoints were located in unique sequences with no apparent homology indicating that nonallelic homologous recombination between flanking segmental duplications is unlikely the rearrangement mechanism underlying the duplication in family vI. next-generation paired-end sequencing was also performed on the duplication in family I. this analysis revealed that the proximal breakpoint is located in a gene-empty region between chromosomal positions chrX: 127, 743, 035 and chrX: 127, 745, 835 (Hg19) . the distal breakpoint [between chromosomal positions 129, 387, 398 and 129, 390, 198 (Hg19) ] was predicted to truncate ZNF280C. Decipher database search there are currently 27 duplications in the Decipher database (http://decipher.sanger.ac.uk/) that overlap or partially overlap the interval from position 128,000,000-134,000,000 on chromosome X. seven of these duplications are >20 Mbp and due to the large size not considered in this study. the remaining 20 duplications are summarized in supplementary table I.
Gpc3 transgenic mice
Families II, III and Iv have an ~4 Mb overlapping region, 0.9 Mb of which can be excluded to be disease causing as the duplication of this region has been observed in the unaffected males in families vII and vIII. the remaining overlapping region includes 13 genes indicating that increased dosage of one or more of these genes might play a role in disease pathogenesis of the tetrad of clinical features. One of these genes is GPC3 (Glypican 3). loss-of-function mutations of GPC3 lead to the simpson-Golabi-Behmel overgrowth syndrome (sGBs; MIM #312870). sGBs patients show gigantism, macrocephaly, macrognathia, large hands/feet, and advanced bone age, while the three patients with GPC3 duplications show prenatal growth retardation, small head circumference/microcephaly, micrognathia, small hands/feet and delayed bone age (Fig. 3) . GPC3 was shown to be a negative regulator of Hedgehog (Hh) signalling during mammalian development. Because Hh signalling promotes growth during development, it has been proposed that the overgrowth observed in sGBs patients is, at least in part, due to the hyperactivation of the Hh signalling pathway (Capurro et al. 2008) . In good agreement with these observations, Gpc3 null mice also display developmental overgrowth (Chiao et al. 2002; Pilia et al. 1996) . Interestingly, except for some common symptoms like genital and digital defects and palatal abnormalities, Xq25q26 duplication patients present with almost reverse phenotypes. the males of families II-Iv share a remarkable common phenotype including reduced growth, a syndromic facial appearance, small hands and feet, severe genital abnormalities and digital malformations Furthermore, the probands of family II and Iv had cleft palate and in addition the proband from family II suffered from oral synechiae (Fig. 3) .
We, therefore, studied Gpc3 transgenic mice where Gpc3 expression is driven by the β-actin promoter (Capurro et al. 2005) . the transgenic mice are viable and, with the exception of a mild kidney dysplasia, they display normal embryonic morphogenesis. Importantly, however, these mice are significantly smaller than their wild-type littermates (Fig. 4) . this result strongly suggests that the duplication of GPC3 in families II-Iv is responsible, at least in part, for the impaired growth of the patients. 
Discussion
We have identified overlapping interstitial Xq25q26 duplications in eight unrelated families. Common features comprise ID, intrauterine-and postnatal growth retardation, feeding difficulties in childhood and small OFC/microcephaly, which are also seen in male patients with microscopically visible Xq duplications. remarkably, ID was not present in the proband of family Iv, who had normal cognitive development and attended normal school. explanations for this exception may include reduced penetrance, compensatory mechanisms due to different genetic background of this patient, or contribution of genes which are not present in the duplicated region in this proband but shared by the duplicated regions of families I, II and III. as shown in Fig. 1 , a 107-kb region of overlap shared by the affected males from family I-III, which includes only the genes AIFM1 and RAB33A fulfils these criteria.
Increased gene dosage of AIFM1 and RAB3A might cause ID the duplications observed in family I, II, III and vI, which all present an ID phenotype, share a region containing the genes AIFM1 and RAB33A. schroer et al. (2012) reported on an Xq25 duplication involving six genes (SMARCA1, OCRL, APLN, XPNPEP2, SASH3, ZDHHC9 and UTP14A) in a patient with autism but without lowe syndrome features. His mother also carrying the duplication was unaffected. the duplications observed in family I and vI cover this duplication entirely and the family II duplication covers it partially.
In line with the observation by schroer et al. we also did not find features suggesting lowe syndrome in the families. In family I and vI the female carriers are affected and in family II the mother is mildly affected. It is interesting to speculate that duplication of one or more genes in combination with duplications of RAB33A and AIFM1 could be involved in X-linked ID also affecting female carriers. AIFM1 encodes the apoptosis-inducing factor (aIF) mitochondrion-associated 1 precursor and RAB33A encodes a small GtP-binding protein.
We investigated RAB33A and AIFM1 transcriptional levels in lymphocytes from affected and unaffected individuals of family I and v. Fine mapping of the duplication in family vI showed that the distal breakpoint is located approximately 600 bp from the 3′ Utr of RAB33A. It is speculative whether this breakpoint leads to deregulation of RAB33A. the index patient in family vI had six brothers who all deceased at birth or before the age of 1 year. all of them had severe growth retardation. Haploinsufficiency of RAB33A in males has not yet been described, and no truncating mutations of this gene have been observed in the 1,000 Genomes project, exome variant server or dbsnP. the Decipher database lists a few smaller duplications overlapping RAB33A and AIFM1, but no phenotype is mentioned. However, two duplications of only 293 and 703 kbp (Decipher ID 266609 and 251804) located at Xq26.3 were found in male patients with ID. the two duplications cover the genes FAM112B and FAM122C as well as the 5′ Utr and coding region of PLAC1. since the duplication in family Iv, where no ID was found, covers the PLAC1 gene but not FAM122B or FAM122C, it is possible that these two genes contribute to the ID phenotype observed in family II and III. However, FAM122B and C are functionally uncharacterized genes and future studies are needed to determine the involvement of these genes in brain function. RAB33A is highly expressed in the brain, especially throughout the cortex and in the hippocampal Ca fields (Cheng et al. 2006) and it belongs to the rab family of small GtPases, and the activity of these GtPases is critical for proper brain function. Mutations in two genes whose protein products affect this pathway; GDI1 (GDP dissociation inhibitor 1), and RAB39B have already been implicated in X-linked ID (D'adamo et al. 1998; Giannandrea et al. 2010) . Increased dosage of RAB33A in the brain may also contribute to the intellectual disabilities observed in the present cases as was proposed for duplications and amplifications including the GDI1 gene at Xq28 (vandewalle et al. 2009 ). AIFM1 encodes the aIF mitochondrion-associated 1 precursor. Mature aIF is a FaD-dependent naDH oxidase targeted to the mitochondrial intermembrane space. Upon apoptogenic stimuli, a soluble form is released by proteolytic cleavage and migrates to the nucleus, where it induces "parthanatos," i.e., caspase-independent fragmentation of chromosomal Dna. Mice with severe reduction in Aif expression have progressive degeneration of terminally differentiated cerebellar and retinal neurons (Klein et al. 2002) and Aif null embryos fail to increase significantly in size after e9, possibly due to abnormal cell death secondary to reduced mitochondrial respiratory chain complex I activity (Brown et al. 2006) . Mutations in AIFM1 were identified in progressive mitochondrial encephalomyopathy with ID, muscular atrophy and epilepsy (Ghezzi et al. 2010) ; and in Cowchock syndrome (CMtX4) a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness and cognitive impairment (rinaldi et al. 2012) . It is thus possible that increased dosage of AIFM1 in critical tissues may contribute to the growth retardation, hypotonia/ muscular weakness, epilepsy and the ID observed in the affected members of family I-III and to the facioscapulohumeral dystrophy observed in the females in family vI.
FAM45B and ENOX2 might play a role in the aetiology of microcephaly, ptosis and digital defects the affected males and females from families II, III and Iv and the female from family v present with bilateral ptosis, small head circumference/microcephaly and digital defects, suggesting that the 200-kb common duplicated region (Fig. 1 ) in these families is critical for these features. this region includes only two genes, ENOX2 and FAM45B.
very little is known about FAM45B. It is also not clear whether FAM45B is a pseudogene or a non-coding rna. ENOX2 (ecto-nOX disulfide-thiol exchanger 2 isoform a) encodes a growth-related cell surface protein. enOX proteins function as terminal oxidases for plasma membrane electron transport. In addition, they carry out protein disulfide-thiol interchange which is essential to the enlargement phase of cell growth (Morre and Morre 2003) . enOX2 has been suggested to play an essential role in the growth of early embryos (Cho and Morre 2009; Morre and Morre 2003) .
In a previous study Xq24q27 region including FAM45B and ENOX2 has been linked to X-linked dominant congenital bilateral isolated ptosis (McMullan et al. 2000) , and the present study suggests that duplication of particular sequences in this interval is involved in the development of dominant X-linked congenital ptosis [OMIM 300245] . the mother in family III and in family v was not exhibiting the ptosis. reduced penetrance was also observed in the original X-linked congenital ptosis family where two females were reported to have the risk-allele but no ptosis. a plausible explanation could be the differences in X-inactivation status in critical tissues. recently, a female with hemihyperplasia, syndactyly of fingers and toes, bilateral 5th finger clinodactyly, short stature, developmental delay, microcephaly and a 11.2-Mb duplication of Xq25q27.1 was reported (ricks et al. 2010) . ricks and colleagues suggested a 1.65-Mb critical region including FAM45B and ENOX2 for some of the clinical features including digital anomalies. It is possible that increased dosage of FAM45B or ENOX2 in critical tissues is responsible for the common phenotype including ptosis, small head circumference/ microcephaly and digital defects observed in the previously published and in the present cases. a very rare 295-kb duplication (1/2,026) within ENOX2 has been observed in a single individual by shaikh et al. (2009) . However, this duplication includes only the first three non-coding exons of the gene and to predict its effect is speculative.
mrna expression analysis
We investigated mrna expression of the duplicated genes in the two critical regions in blood obtained from individuals of family I and v. We did not observe significant FAM45B or ENOX2 expression differences in the patient from family v, and RAB33A expression was only significantly increased in the two affected brothers in family I, when compared with controls and unaffected family members. though we have not ruled out possible positional effects on other genes in the region, these results suggest that duplications do not necessarily lead to altered mrna expression, at least in blood. However, the expression profiles of these genes may be different in critical tissues under development, and mrna expression also depends on other factors such as binding of transcription factors and the epigenetic state of the Dna, both of which are tissue dependent. Furthermore the genetic backgrounds of these families are different and this may have a substantial effect on expression of individual genes.
Glypican 3 and IGsF1 are associated with typical syndromic features the males of families II, III and Iv share a distinct facial appearance with congenital bilateral ptosis and large protruding ears as well as cleft palate in two of them. Furthermore, they all have small hands and feet, obvious genital abnormalities and digital malformations. the critical region for the observed features includes 13 genes suggesting that increased dosage of one or more of these genes might play a role in disease pathogenesis (Fig. 1) . the most likely candidate gene in this region is GPC3 and we show that Gpc3 transgenic mice are significantly smaller than the wild-type littermates (Fig. 4) , indicating that the duplication of GPC3 in families II-Iv is responsible, at least in part, for the impaired growth of the patients. notably, an intragenic duplication of GPC3 is described in a Decipher patient (Decipher ID 258050) with the phenotype "large for gestational age" which fits the sGB syndrome phenotype.
the severe genital abnormalities including glandular hypospadia, and hypoplastic scrotum and penis might be caused by the duplication of IGSF1, encoding a member of the immunoglobulin-like domain-containing molecule superfamily. this gene is expressed in the developing pituitary primordium and in adult pituitary gland and testis. there are four cases with duplication smaller than 1 Mb covering IGSF1 in the Decipher database and a phenotype is provided for two cases. In one case (Decipher ID 267829) a male is affected by inguinal hernia, ID, microcephaly and plagiocephaly; and in the other case (Decipher ID 258875) a young boy is affected by blepharophimosis, cleft palate, depressed nasal tip, epicanthus and developmental delay. the latter case is special as his mother received valproate for her seizures, also during pregnancy. His weight at birth was 3.46 kg and he was diagnosed with microcephaly, but at the age of 6 years his head was of average size. He had overlapping toes and received surgery for syndactyly on his right hand. His genitalia, however, were not investigated. He showed severe developmental delay, but an IQ test was not carried out. this case suggests that increased IGSF1 dosage may be associated with syndromic features, but cannot alone explain all the phenotypic characteristics observed in families II-Iv. On the other hand, IGSF1 mutations have recently been associated with hypothyroidism and testicular enlargement in males (sun et al. 2012) , suggesting that increased IGSF1 dosage may contribute to the genital abnormalities observed in families II-Iv. synopsis In summary, our study suggests that interstitial duplications of Xq25q26 exhibit a recognisable microduplication syndrome comprising a remarkable facial appearance with congenital bilateral ptosis, cleft palate and large protruding ears, genital and digital defects. Comparison of the duplications and the symptoms suggests several critical regions including a 107-kb region containing RAB33A and AIFM1 for ID and a 200-kb region containing ENOX2 and FAM45B for X-linked congenital ptosis, associated with syn-and clinodactyly. In addition, duplication of GPC3 might be responsible for the growth impairment in these patients. Identification of additional patients with Xq25q26 duplications will further contribute to the delineation of the clinical spectrum associated with this region. 
